N,N-Dimethylethanaminium

N,N-Dimethylethanaminium

SCHEMBL446422

C=C(C)C(=O)NCC.CCN(C)C

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 1/20 0.38
PLAAT3 P53816 1/20 0.33
PLAAT5 Q96KN8 1/20 0.33
PLAAT2 Q9NWW9 1/20 0.33
PLAAT4 Q9UL19 1/20 0.33
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP9 P14780 1/20 0.32
MMP8 P22894 1/20 0.32
THRB P10828 1/20 0.31
KMT2A Q03164 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
CHRM1 P11229 2/20 0.30
MCL1 Q07820 1/20 0.30
CHRM2 P08172 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N,N-Dimethylethanaminium SCHEMBL7057093 0.98 TGFBR1 (0.37) TGFBR1PLAAT3PLAAT5PLAAT2PLAAT4
Trimethylammonium SCHEMBL444000 0.91 TGFBR1 (0.41) TGFBR1PLAAT3PLAAT5PLAAT2PLAAT4
Trimethylammonium SCHEMBL176133 0.89 TGFBR1 (0.39) TGFBR1PLAAT3PLAAT5PLAAT2PLAAT4
Trimethylammonium SCHEMBL869214 0.89 TGFBR1 (0.39) TGFBR1PLAAT3PLAAT5PLAAT2PLAAT4
Trimethylammonium SCHEMBL895151 0.89 TGFBR1 (0.39) TGFBR1PLAAT3PLAAT5PLAAT2PLAAT4
Trimethylammonium SCHEMBL28049014 0.89 TGFBR1 (0.39) TGFBR1PLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL14949 0.89
SCHEMBL28049100 0.87 TGFBR1 (0.38) TGFBR1PLAAT3PLAAT5PLAAT2PLAAT4
Potassium SCHEMBL3659436 0.86
Hydrochloric Acid SCHEMBL15846120 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1825884-B1 Brightening and/or colouring agent with reduced potential for irritation HENKEL AG & CO KGAA (DE) 2017-08-16 EP claimed
EP-1813260-B1 Bleaching and/or colouring agent with reduced potential for irritation HENKEL AG & CO KGAA (DE) 2017-05-31 EP claimed
EP-1825884-A2 Brightening and/or colouring agent with reduced potential for irritation Henkel Kommanditgesellschaft auf Aktien (DE) 2007-08-29 EP claimed
EP-1813260-A2 Bleaching and/or colouring agent with reduced potential for irritation Henkel Kommanditgesellschaft auf Aktien (DE) 2007-08-01 EP claimed
EP-1825884-B1 Brightening and/or colouring agent with reduced potential for irritation HENKEL AG & CO KGAA (DE) 2017-08-16 EP disclosed
EP-1813260-B1 Bleaching and/or colouring agent with reduced potential for irritation HENKEL AG & CO KGAA (DE) 2017-05-31 EP disclosed
EP-3052197-A1 PERFORMANCE-ENHANCED HAIR TREATMENT COMPOSITION Henkel AG & Co. KGaA (DE) 2016-08-10 EP disclosed
US-20160199282-A1 PERFORMANCE-ENHANCED HAIR TREATMENT COMPOSITION HENKEL AG & CO. KGAA (DE) 2016-07-14 US disclosed
EP-2164456-B1 HAIR TREATMENT AGENT CONTAINING OLIGO-PEPTIDES HENKEL AG & CO KGAA (DE) 2016-05-11 EP disclosed
WO-2015062596-A1 HAIR TREATMENT AGENT CONTAINING L-CARNITINE OR AN L-CARNITINE DERIVATIVE AND AN OLIGOPEPTIDE CONTAINING THE SEQUENCE GLU-GLU-GLU HENKEL AG & CO. KGAA (DE) 2015-05-07 WO disclosed
WO-2015048951-A1 PERFORMANCE-ENHANCED HAIR TREATMENT COMPOSITION HENKEL AG & CO. KGAA (DE) 2015-04-09 WO disclosed
US-20140271520-A1 NON-WEIGHING HAIR PREPARATIONS HENKEL AG & CO., KGAA (DE) 2014-09-18 US disclosed
US-6576086-B1 Reacting amino- or ammonium-containing polymers with sizing agent; drainage of interfering substances BASF AKTIENGESELLSCHAFT (DE) 2003-06-10 US disclosed
EP-1167504-A1 Polyvinylpyrridinium derivatives as anti-dye transfer agents National Starch and Chemical Investment Holding Corporation (US) 2002-01-02 EP disclosed
US-6235835-B1 STARCH IS MODIFIED WITH AT LEAST ONE CATIONIC POLYMER BASF AKTIENGESELLSCHAFT (DE) 2001-05-22 US disclosed
US-6191098-B1 ANIOINIC SURFACTANTS AND AMPHOTERIC SURFACTANTS NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION 2001-02-20 US disclosed
US-6160050-A Polymer-modified starch, method for its production, and its use BASF AKTIENGESELLSCHAFT (DE) 2000-12-12 US disclosed
US-5851300-A Cationic modification of starch and use of the cationically modified starch BASF AKTIENGESELLSCHAFT (DE) 1998-12-22 US disclosed
US-5846924-A Use of vinylpyrrolidone and vinylimidazole copolymers as detergent additives, novel polymers of vinylpyrrolidone and of vinylimidazole, and preparation thereof BASF AKTIENGESELLSCHAFT (DE) 1998-12-08 US disclosed
US-5627151-A WASHING TEXTILES USING DYE TRANSFER INHIBITOR BASF AKTIENGESELLSCHAFT (DE) 1997-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160199282-A1 PERFORMANCE-ENHANCED HAIR TREATMENT COMPOSITION KRT18, YWHAZ, PHYKPL TGFBR1 4045/4885PLAAT3 1526/4885PLAAT5 3498/4885
US-20140271520-A1 NON-WEIGHING HAIR PREPARATIONS KRT18, KRTCAP2, PSMB10 TGFBR1 3774/4885PLAAT3 2107/4885PLAAT5 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.